Mirador Capital Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-72,355
Closed -$186K 201
2024
Q2
$186K Buy
+72,355
New +$186K 0.04% 180